Market Insights Consumer OTC Pharmaceuticals

Sleep Aids - Netherlands

Netherlands

Revenue in the Sleep Aids market amounts to €39.99m in 2024. The market is expected to grow annually by 2.81% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€1,930m in 2024).
In relation to total population figures, per person revenues of €2.26 are generated in 2024.

Key regions: Philippines, Indonesia, United Kingdom, Canada, Thailand

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Sleep Aids market in Netherlands has been experiencing significant growth in recent years. Customer preferences are shifting towards natural and non-habit forming sleep aids, leading to an increase in the demand for herbal and homeopathic products. Additionally, the rising prevalence of sleep disorders and the increasing awareness about the importance of sleep have contributed to the growth of the market.

Customer preferences: Customers in Netherlands are increasingly seeking natural and non-habit forming sleep aids. They are more inclined towards herbal and homeopathic products that offer a holistic approach to sleep. This shift in preference can be attributed to the growing awareness about the potential side effects and dependency associated with traditional sleep aids. Customers are also looking for products that promote relaxation and stress reduction, as these factors are often linked to sleep disturbances.

Trends in the market: One of the key trends in the Sleep Aids market in Netherlands is the growing popularity of herbal and homeopathic sleep aids. These products are formulated with natural ingredients that are believed to promote better sleep without causing any adverse effects. Manufacturers are capitalizing on this trend by introducing a wide range of herbal sleep aids that cater to different customer needs. This trend is expected to continue as customers become more conscious about their health and seek alternative solutions for sleep problems. Another trend in the market is the increasing availability of sleep aids in various forms such as tablets, capsules, and sprays. Manufacturers are diversifying their product offerings to cater to different customer preferences and needs. For example, some customers may prefer tablets for convenience, while others may prefer sprays for faster absorption. This trend is driven by the need to provide customers with options that suit their individual preferences and lifestyles.

Local special circumstances: Netherlands has a well-developed healthcare system and a high level of healthcare expenditure. This enables easy access to healthcare services and products, including sleep aids. The country also has a high level of health awareness among its population, which contributes to the demand for sleep aids. Additionally, the Netherlands has a high prevalence of sleep disorders, which further drives the demand for sleep aids.

Underlying macroeconomic factors: The Sleep Aids market in Netherlands is influenced by several underlying macroeconomic factors. The country has a stable economy and a high standard of living, which allows consumers to spend on healthcare products. Furthermore, the aging population in Netherlands is more prone to sleep disorders, creating a larger customer base for sleep aids. The increasing urbanization and hectic lifestyles also contribute to sleep problems, leading to a higher demand for sleep aids. Overall, the favorable economic conditions and the changing demographics in Netherlands are driving the growth of the Sleep Aids market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.